Stuart M. Levitz

20.1k total citations · 2 hit papers
178 papers, 14.4k citations indexed

About

Stuart M. Levitz is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Stuart M. Levitz has authored 178 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Epidemiology, 113 papers in Infectious Diseases and 45 papers in Immunology. Recurrent topics in Stuart M. Levitz's work include Fungal Infections and Studies (120 papers), Antifungal resistance and susceptibility (112 papers) and Nail Diseases and Treatments (44 papers). Stuart M. Levitz is often cited by papers focused on Fungal Infections and Studies (120 papers), Antifungal resistance and susceptibility (112 papers) and Nail Diseases and Treatments (44 papers). Stuart M. Levitz collaborates with scholars based in United States, United Kingdom and Australia. Stuart M. Levitz's co-authors include Gordon D. Brown, Mihai G. Netea, Theodore C. White, Neil A. R. Gow, David W. Denning, Charles A. Specht, Richard D. Diamond, Chrono K. Lee, Michael K. Mansour and Shmuel Shoham and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Stuart M. Levitz

175 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hidden Killers: Human Fungal Infections

2012 3.1k citations Stuart M. Levitz et al. profile →
Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.

1988 547 citations Stuart M. Levitz, Richard D. Diamond et al. profile →

Peers

Countries citing papers authored by Stuart M. Levitz

Since Specialization

Citations

This map shows the geographic impact of Stuart M. Levitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart M. Levitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart M. Levitz more than expected).

Fields of papers citing papers by Stuart M. Levitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart M. Levitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart M. Levitz. The network helps show where Stuart M. Levitz may publish in the future.

Co-authorship network of co-authors of Stuart M. Levitz

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart M. Levitz. A scholar is included among the top collaborators of Stuart M. Levitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart M. Levitz. Stuart M. Levitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model 2024 ·PLoS ONE ·Adam O. Whelan, Helen C. Flick-Smith, Nicola J. Walker, Ambily Abraham, Stuart M. Levitz, Gary R. Ostroff, Petra C. F. Oyston	1
2	Dysregulated pulmonary inflammatory responses exacerbate the outcome of secondary aspergillosis following influenza 2023 ·mBio ·Chrono K. Lee, Lorena V. N. Oliveira, Ali Akalin, Charles A. Specht, (unknown), (unknown), Zaida G. Ramirez‐Ortiz, Jennifer Wang, Stuart M. Levitz	8
3	Immunological correlates of protection following vaccination with glucan particles containing Cryptococcus neoformans chitin deacetylases 2023 ·npj Vaccines ·Ruiying Wang, Lorena V. N. Oliveira, (unknown), (unknown), Chrono K. Lee, (unknown), (unknown), Gary R. Ostroff, Charles A. Specht, Stuart M. Levitz	10
4	Similar evolutionary trajectories in an environmental Cryptococcus neoformans isolate after human and murine infection 2023 ·Proceedings of the National Academy of Sciences ·Poppy Sephton-Clark, Scott A. McConnell, Nina T. Grossman, Rosanna P. Baker, Quigly Dragotakes, Yunfan Fan, Man Shun Fu, (unknown), (unknown), J. Marie Hardwick, (unknown), Stuart M. Levitz, Joshua D. Nosanchuk, Shmuel Shoham, Daniel F. Q. Smith, (unknown), Winston Timp, Maggie P. Wear, Christina A. Cuomo, Arturo Casadevall	6
5	One Step Purification—Vaccine Delivery System 2023 ·Pharmaceutics ·Ernesto R. Soto, Charles A. Specht, Chrono K. Lee, Stuart M. Levitz, Gary R. Ostroff	7
6	Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles 2022 ·mBio ·Charles A. Specht, E. Jane Homan, Chrono K. Lee, (unknown), (unknown), (unknown), Ambily Abraham, Florentina Rus, Gary R. Ostroff, Stuart M. Levitz	19
7	Structural basis of Blastomyces Endoglucanase-2 adjuvancy in anti-fungal and -viral immunity 2021 ·PLoS Pathogens ·(unknown), Hannah E. Dobson, (unknown), Gregory C. Kujoth, Junfeng Huang, (unknown), (unknown), Huafeng Wang, Nitin T. Supekar, J. Scott Fites, (unknown), (unknown), Charles A. Specht, Stuart M. Levitz, Parastoo Azadi, Lingjun Li, M. Suresh, Bruce S. Klein, Marcel Wüthrich	9
8	Chitosan Biosynthesis and Virulence in the Human Fungal Pathogen Cryptococcus gattii 2019 ·mSphere ·Woei C. Lam, Rajendra Upadhya, Charles A. Specht, (unknown), Camaron R. Hole, Stuart M. Levitz, Jennifer K. Lodge	24
9	Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice 2018 ·Vaccine ·George S. Deepe, (unknown), Gary R. Ostroff, Ambily Abraham, Charles A. Specht, Haibin Huang, Stuart M. Levitz	27
10	Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species 2017 ·mBio ·Charles A. Specht, Chrono K. Lee, Haibin Huang, (unknown), Jianhua Liu, (unknown), (unknown), (unknown), Payam Khoshkenar, Ambily Abraham, Zu T. Shen, Jennifer K. Lodge, Ali Akalin, E. Jane Homan, Gary R. Ostroff, Stuart M. Levitz	77
11	The Phenotype of the Cryptococcus-Specific CD4+ Memory T-Cell Response Is Associated With Disease Severity and Outcome in HIV-Associated Cryptococcal Meningitis 2013 ·The Journal of Infectious Diseases ·Joseph N Jarvis, Joseph P. Casazza, (unknown), Graeme Meintjes, Stephen D Lawn, Stuart M. Levitz, Thomas S. Harrison, Richard A. Koup	105
12	Distinct patterns of dendritic cell cytokine release stimulated by beta-glucans and Toll-Like receptor agonists (98.33) 2009 ·The Journal of Immunology ·Haibin Huang, Gary R. Ostroff, Stuart M. Levitz	4
13	Cryptococcus neoformans Glycoantigens Are Captured by Multiple Lectin Receptors and Presented by Dendritic Cells 2006 ·The Journal of Immunology ·Michael K. Mansour, Eicke Latz, Stuart M. Levitz	98
14	The Contribution of the Toll-Like/IL-1 Receptor Superfamily to Innate and Adaptive Immunity to Fungal Pathogens In Vivo 2004 ·The Journal of Immunology ·Silvia Bellocchio, Claudia Montagnoli, Silvia Bozza, Roberta Gaziano, (unknown), Salamatu S. Mambula, Annunciata Vecchi, Alberto Mantovani, Stuart M. Levitz, Luigina Romani	402
15	Inhibition of Mitogen-Activated Protein Kinase Signaling by Chloroquine 2002 ·The Journal of Immunology ·Stephen M. Weber, (unknown), Stuart M. Levitz	58
16	Determination of the pH of theCryptococcus neoformansvacuole 2002 ·Medical Mycology ·Thomas S. Harrison, (unknown), Elizabeth R. Simons, Stuart M. Levitz	17
17	Toll-Like Receptor 4 Mediates Intracellular Signaling Without TNF-α Release in Response to Cryptococcus neoformans Polysaccharide Capsule 2001 ·The Journal of Immunology ·Shmuel Shoham, Chao Huang, Jianmin Chen, Douglas T. Golenbock, Stuart M. Levitz	252
18	Human Immunodeficiency Virus Type 1 Infection of Alveolar Macrophages Impairs Their Innate Fungicidal Activity 2000 ·American Journal of Respiratory and Critical Care Medicine ·Michael H. Ieong, Christine C. Reardon, Stuart M. Levitz, Hardy Kornfeld	23
19	Chloroquine Interferes with Lipopolysaccharide-Induced TNF-α Gene Expression by a Nonlysosomotropic Mechanism 2000 ·The Journal of Immunology ·Stephen M. Weber, Stuart M. Levitz	104
20	Inhibition and killing of fungi by the polyamine oxidase-polyamine system 1990 ·Antonie van Leeuwenhoek ·Stuart M. Levitz, David DiBenedetto, Richard D. Diamond	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact